Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/086060 stock hub

KOSDAQ/086060 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/086060is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.4B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/086060

In the news

Latest news · KOSDAQ/086060

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E9.9

P25 n/aP50 n/aP75 n/a

ROE7.2

P25 n/aP50 n/aP75 n/a

ROIC7.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/086060 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

KRW

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	42
Enterprise value	KRW 27.4B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 37.4B
Price	KRW 4,340
Price currency	KRW
Rev Per Employee	2,161,642,185x
Sic	2834
Symbol	kosdaq/086060
Website	https://www.genebiotech.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.14%
EV Earnings	7.24x
EV/EBIT	6.87x
EV/EBITDA	5.1x
EV/FCF	7.11x
EV/Sales	0.3x
FCF yield	10.32%
P/B ratio	0.68x
P/E ratio	9.86x
P/S ratio	0.41x
PE Ratio10 Y	32.74x
PE Ratio3 Y	12.15x
PE Ratio5 Y	31.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.4%
EBITDA Margin	5.93%
FCF margin	4.25%
Gross margin	15.7%
Gross Profit	KRW 14.3B
Gross Profit Growth	6.63%
Gross Profit Growth Q	-9.58%
Gross Profit Growth3 Y	11.27%
Gross Profit Growth5 Y	8.61%
Net Income	KRW 3.8B
Net Income Growth	32.23%
Net Income Growth Q	14.83%
Net Income Growth3 Y	35.49%
Pretax Margin	4.86%
Profit Margin	4.17%
Profit Per Employee	KRW 90.2M
ROA	3.38
Roa5y	2.36
ROCE	6.67
ROE	7.15
Roe5y	4.16
ROIC	7.53
Roic5y	4.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.88%
Cagr15y	5.9%
Cagr1y	24.73%
Cagr20y	-1.1%
Cagr3y	0.31%
Cagr5y	-8.1%
Div CAGR10	5.24%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	32.13
EPS Growth Q	14.54
EPS Growth3 Y	35.49
OCF Growth Q	1,041.86%
OCF Growth10 Y	11.32%
OCF Growth5 Y	25.03%
Revenue Growth	9.44x
Revenue Growth Q	-6.76x
Revenue Growth3 Y	3.14x
Revenue Growth5 Y	8.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.23
Assets	KRW 75.6B
Cash	KRW 24.9B
Current Assets	KRW 54.7B
Current Liabilities	KRW 15.7B
Debt	KRW 15B
Debt EBITDA	KRW 2.78
Debt Equity	KRW 0.27
Debt FCF	KRW 3.88
Equity	KRW 55B
Interest Coverage	7.1
Liabilities	KRW 20.6B
Long Term Assets	KRW 20.9B
Long Term Liabilities	KRW 4.9B
Net Cash	KRW 9.9B
Net Cash By Market Cap	KRW 26.6
Net Cash Growth	32.2%
Net Debt EBITDA	KRW -1.85
Net Debt Equity	KRW -0.18
Net Debt FCF	KRW -2.58
Tangible Book Value	KRW 54.4B
Tangible Book Value Per Share	KRW 6,318
WACC	5.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.48
Inventory Turnover	4.92
Net Working Capital	KRW 24.2B
Quick ratio	2.39
Working Capital	KRW 39B
Working Capital Turnover	KRW 2.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	KRW 50
Dividend Years	1
Dividend Yield	1.15%
Ex Div Date	2025-12-29
Last Dividend	KRW 50

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-17.29%
1Y total return	24.71%
200-day SMA	4,421.4
3Y total return	0.93%
50-day SMA	4,925.7
50-day SMA vs 200-day SMA	50over200
5Y total return	-34.46%
All Time High	11,100
All Time High Change	-60.9%
All Time High Date	2016-06-08
All Time Low	1,070
All Time Low Change	305.61%
All Time Low Date	2008-10-29
ATR	172.9
Beta	0.43
Beta1y	0.47
Beta2y	0.37
Ch YTD	8.23
High	4,470
High52	5,990
High52 Date	2026-02-12
High52ch	-27.55%
Low	4,200
Low52	3,400
Low52 Date	2025-05-12
Low52ch	27.65%
Ma50ch	-11.89%
Price vs 200-day SMA	-1.84%
RSI	22.61
RSI Monthly	52.17
RSI Weekly	43.16
Sharpe ratio	0.63x
Sortino ratio	1.44
Total Return	1.08%
Tr YTD	8.23
Tr15y	136.17%
Tr1m	-7.76%
Tr1w	-7.95%
Tr3m	-5.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 4B
Operating Income Growth	3.95
Operating Income Growth Q	-32.19
Operating Income Growth3 Y	36.91
Operating margin	4.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,714,621%
Net Borrowing	-992,939,580
Shares Insiders	33.97%
Shares Out	8,610,587
Shares Qo Q	0.02%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 3.9B
Average Volume	37,641.7x
Bv Per Share	6,386
CAPEX	KRW -3.8B
Ch10y	-20.22
Ch15y	113.8
Ch1m	-7.76
Ch1w	-7.95
Ch1y	24.71
Ch20y	-33.23
Ch3m	-5.65
Ch3y	0.93
Ch5y	-34.83
Ch6m	20.56
Change	-0.8%
Change From Open	-0.91
Close	4,375
Days Gap	0.11
Depreciation Amortization	1,386,623,000
Dollar Volume	157,381,420
Earnings Date	2026-05-15
EBIT	KRW 4B
EBITDA	KRW 5.4B
EPS	KRW 440
F Score	6
FCF	KRW 3.9B
FCF EV Yield	14.06x
FCF Per Share	KRW 448
Financing CF	-992,939,570
Fiscal Year End	December
Founded	2,000
Graham Number	7951.17513
Graham Upside	83.21
Income Tax	KRW 625.9M
Investing CF	-7,312,394,850
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Lynch Fair Value	KRW 11,000
Lynch Upside	153.5
Ma150	4,406.4
Ma150ch	-1.51%
Ma20	4,763.5
Ma20ch	-8.89%
Net CF	-692,080,150
Next Earnings Date	2026-05-15
Open	4,380
P FCF Ratio	9.69
P OCF Ratio	4.91
Payment Date	2026-04-22
Position In Range	51.85
Ppne	16,972,339,430
Price Date	2026-05-08
Price EBITDA	KRW 6.94
Ptbv Ratio	0.69
Relative Volume	0.96x
Revenue	90,788,971,770x
Tax By Revenue	0.69x
Tax Rate	14.18%
Tr20y	-19.81%
Tr6m	20.56%
Volume	36,263
Z Score	3.63

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KOSDAQ/086060 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$50.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

1 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2025-12-29

Performance

KOSDAQ/086060 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/086060?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+34.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KOSDAQ/086060 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

22.6

Below 30: short-term oversold

Price vs 200-day MA

-1.8%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/086060

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/086060 stock rating?

kosdaq/086060 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/086060 analysis?

The full report lives at /stocks/kosdaq/086060/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/086060?

The latest report frames kosdaq/086060 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/086060 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.